Identification of PKCα Isoform-Specific Effects in Cardiac Myocytes Using Antisense Phosphorothioate Oligonucleotides (original) (raw)
Research ArticleArticle
, Mika Ilves, Sampsa Pikkarainen, Heikki Tokola, Jarkko Ronkainen, Olli Vuolteenaho, Juhani Leppäluoto and Heikki Ruskoaho
Molecular Pharmacology December 2002, 62 (6) 1482-1491; DOI: https://doi.org/10.1124/mol.62.6.1482
Abstract
Members of the mammalian protein kinase C (PKC) superfamily play key regulatory roles in multiple cellular processes. In the heart, PKC signaling is involved in hypertrophic agonist-induced gene expression and hypertrophic growth. To investigate the specific function of PKC signaling in regulating cardiomyocyte growth, we used antisense oligonucleotides to inhibit PKC α, the major isozyme present in the neonatal heart. Transfection of cultured neonatal cardiomyocytes with antisense PKCα oligonucleotides resulted in a marked reduction in both PKCα mRNA and protein levels. PKCα antisense treatment also reduced phenylephrine (PE)-induced PKC activity and perinuclear translocation of PKCα. Antisense inhibition of PKCα led to reduction of PE-induced increase in skeletal α-actin mRNA levels and atrial natriuretic peptide (ANP) secretion but had no significant effects on PE-induced β-myosin heavy chain, ANP, or B-type natriuretic peptide (BNP) gene expression. On the other hand, antisense PKCα treatment attenuated endothelin-1–induced increase in ANP and BNP peptide secretion, whereas endothelin-1–induced gene expression of ANP and BNP remained unchanged. The hypertrophic agonist-induced growth of cardiomyocytes, characterized by increased [3H]leucine incorporation, was not affected with antisense PKCα treatment. Furthermore, we found that PE-induced increase in extracellular signal-regulated kinase (ERK) activity was partially inhibited by antisense PKCα treatment, implicating ERK as a downstream mediator for PKCα signaling. These results indicate that PKCα isozyme is involved in hypertrophic signaling in cardiomyocytes and provide novel strategies for future studies to identify other cellular targets controlled selectively by PKCα or other PKC isozymes.
- The American Society for Pharmacology and Experimental Therapeutics
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.